{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,16]],"date-time":"2026-10-16T18:39:05Z","timestamp":1792175945278,"version":"4.4.0"},"reference-count":62,"publisher":"Springer Science and Business Media LLC","issue":"5","license":[{"start":{"date-parts":[[2023,7,10]],"date-time":"2023-07-10T00:00:00Z","timestamp":1688947200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2023,7,10]],"date-time":"2023-07-10T00:00:00Z","timestamp":1688947200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"funder":[{"DOI":"10.13039\/501100021771","name":"Student Research Committee, Tabriz University of Medical Sciences","doi-asserted-by":"publisher","award":["grant number: 70831"],"award-info":[{"award-number":["grant number: 70831"]}],"id":[{"id":"10.13039\/501100021771","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Inflammopharmacol"],"published-print":{"date-parts":[[2023,10]]},"DOI":"10.1007\/s10787-023-01271-4","type":"journal-article","created":{"date-parts":[[2023,7,10]],"date-time":"2023-07-10T16:04:20Z","timestamp":1689005060000},"page":"2213-2220","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":25,"title":["Clinical efficacy and safety of melatonin supplementation in multiple sclerosis: a systematic review"],"prefix":"10.1007","volume":"31","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-3681-9408","authenticated-orcid":false,"given":"Soroush","family":"Morsali","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6861-0209","authenticated-orcid":false,"given":"Zahra","family":"Sabahi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0003-7939-5497","authenticated-orcid":false,"given":"Javad","family":"Kakaei","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3046-9753","authenticated-orcid":false,"given":"Zahra","family":"Hakimzadeh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0001-6197-5747","authenticated-orcid":false,"given":"Sana","family":"Hamidi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5977-6127","authenticated-orcid":false,"given":"Elnaz","family":"Gholipour-khalili","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2325-5631","authenticated-orcid":false,"given":"Sarvin","family":"Sanaie","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7613-3913","authenticated-orcid":false,"given":"Mahnaz","family":"Talebi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9723-0109","authenticated-orcid":false,"given":"Amirreza","family":"Naseri","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2023,7,10]]},"reference":[{"issue":"8","key":"1271_CR1","doi-asserted-by":"publisher","first-page":"1585","DOI":"10.1007\/s11064-014-1347-6","volume":"39","author":"M Adamczyk-Sowa","year":"2014","unstructured":"Adamczyk-Sowa M, Pierzchala K, Sowa P, Mucha S, Sadowska-Bartosz I, Adamczyk J, Hartel M (2014a) Melatonin acts as antioxidant and improves sleep in MS patients. Neurochem Res 39(8):1585\u20131593. https:\/\/doi.org\/10.1007\/s11064-014-1347-6","journal-title":"Neurochem Res"},{"key":"1271_CR2","doi-asserted-by":"publisher","DOI":"10.1155\/2017\/7905148","author":"M Adamczyk-Sowa","year":"2017","unstructured":"Adamczyk-Sowa M, Galiniak S, Zyracka E, Grzesik M, Napar\u0142o K, Sowa P, Bartosz G, Sadowska-Bartosz I (2017) Oxidative modification of blood serum proteins in multiple sclerosis after interferon beta and melatonin treatment. Oxidative Med Cell Longev. https:\/\/doi.org\/10.1155\/2017\/7905148","journal-title":"Oxidative Med Cell Longev"},{"key":"1271_CR3","unstructured":"Adamczyk-Sowa M, Pierzchala K, Sowa P, Polaniak R, Kukla M, Hartel M (2014b) Influence of melatonin supplementation on serum antioxidative properties and impact of the quality of life in multiple sclerosis patients. J Physiol Pharmacol 65(4), 543\u2013550. http:\/\/ovidsp.ovid.com\/ovidweb.cgi?T=JS&PAGE=reference&D=med11&NEWS=N&AN=25179086"},{"key":"1271_CR4","unstructured":"Adamczyk-Sowa M, Sowa P, Adamczyk J, Niedziela N, Misiolek H, Owczarek M, Zwirska-Korczala K (2016a) Effect of melatonin supplementation on plasma lipid hydroperoxides, homocysteine concentration and chronic fatigue syndrome in multiple sclerosis patients treated with interferons-beta and mitoxantrone. J Physiol Pharmacol 67(2), 235\u2013242. http:\/\/ovidsp.ovid.com\/ovidweb.cgi?T=JS&PAGE=reference&D=med13&NEWS=N&AN=27226183"},{"key":"1271_CR5","doi-asserted-by":"crossref","unstructured":"Adamczyk-Sowa M, Sowa P, Mucha S, Zostawa J, Mazur B, Owczarek M, Pierzchala K (2016b) Changes in serum ceruloplasmin levels based on immunomodulatory treatments and melatonin supplementation in multiple sclerosis patients. Med Sci Monitor 22:2484\u20132491. http:\/\/ovidsp.ovid.com\/ovidweb.cgi?T=JS&PAGE=reference&D=med13&NEWS=N&AN=27420299https:\/\/www.ncbi.nlm.nih.gov\/pmc\/articles\/PMC4958372\/pdf\/medscimonit-22-2484.pdf","DOI":"10.12659\/MSM.895702"},{"key":"1271_CR6","doi-asserted-by":"publisher","DOI":"10.1111\/jpi.12442","author":"N Alvarez-Sanchez","year":"2017","unstructured":"Alvarez-Sanchez N, Cruz-Chamorro I, Diaz-Sanchez M, Sarmiento-Soto H, Medrano-Campillo P, Martinez-Lopez A, Lardone PJ, Guerrero JM, Carrillo-Vico A (2017) Melatonin reduces inflammatory response in peripheral T helper lymphocytes from relapsing-remitting multiple sclerosis patients. J Pineal Res. https:\/\/doi.org\/10.1111\/jpi.12442","journal-title":"J Pineal Res"},{"issue":"Suppl 3","key":"1271_CR7","doi-asserted-by":"publisher","first-page":"S16","DOI":"10.1212\/WNL.0b013e3181dbb664","volume":"74","author":"LJ Balcer","year":"2010","unstructured":"Balcer LJ, Frohman EM (2010) Evaluating loss of visual function in multiple sclerosis as measured by low-contrast letter acuity. Neurology 74(Suppl 3):S16-23. https:\/\/doi.org\/10.1212\/WNL.0b013e3181dbb664","journal-title":"Neurology"},{"issue":"12","key":"1271_CR8","doi-asserted-by":"publisher","first-page":"1167","DOI":"10.1007\/s40263-019-00680-w","volume":"33","author":"FMC Besag","year":"2019","unstructured":"Besag FMC, Vasey MJ, Lao KSJ, Wong ICK (2019) Adverse events associated with melatonin for the treatment of primary or secondary sleep disorders: a systematic review. CNS Drugs 33(12):1167\u20131186. https:\/\/doi.org\/10.1007\/s40263-019-00680-w","journal-title":"CNS Drugs"},{"issue":"12","key":"1271_CR9","doi-asserted-by":"publisher","first-page":"1151","DOI":"10.1111\/j.1525-1497.2005.0243.x","volume":"20","author":"N Buscemi","year":"2005","unstructured":"Buscemi N, Vandermeer B, Hooton N, Pandya R, Tjosvold L, Hartling L, Baker G, Klassen TP, Vohra S (2005) The efficacy and safety of exogenous melatonin for primary sleep disorders. A meta-analysis. J Gen Intern Med 20(12):1151\u20131158. https:\/\/doi.org\/10.1111\/j.1525-1497.2005.0243.x","journal-title":"J Gen Intern Med"},{"issue":"1158","key":"1271_CR10","doi-asserted-by":"publisher","first-page":"285","DOI":"10.1136\/postgradmedj-2020-139319","volume":"98","author":"V Chan","year":"2022","unstructured":"Chan V, Lo K (2022) Efficacy of dietary supplements on improving sleep quality: a systematic review and meta-analysis. Postgrad Med J 98(1158):285\u2013293. https:\/\/doi.org\/10.1136\/postgradmedj-2020-139319","journal-title":"Postgrad Med J"},{"key":"1271_CR11","doi-asserted-by":"publisher","first-page":"245","DOI":"10.1016\/j.bbi.2021.01.034","volume":"93","author":"JH Cho","year":"2021","unstructured":"Cho JH, Bhutani S, Kim CH, Irwin MR (2021) Anti-inflammatory effects of melatonin: a systematic review and meta-analysis of clinical trials. Brain Behav Immun 93:245\u2013253. https:\/\/doi.org\/10.1016\/j.bbi.2021.01.034","journal-title":"Brain Behav Immun"},{"issue":"6","key":"1271_CR12","doi-asserted-by":"publisher","first-page":"990","DOI":"10.1210\/er.2018-00084","volume":"39","author":"J Cipolla-Neto","year":"2018","unstructured":"Cipolla-Neto J, Amaral FGD (2018) Melatonin as a hormone: new physiological and clinical insights. Endocr Rev 39(6):990\u20131028. https:\/\/doi.org\/10.1210\/er.2018-00084","journal-title":"Endocr Rev"},{"issue":"9648","key":"1271_CR13","doi-asserted-by":"publisher","first-page":"1502","DOI":"10.1016\/s0140-6736(08)61620-7","volume":"372","author":"A Compston","year":"2008","unstructured":"Compston A, Coles A (2008) Multiple sclerosis. Lancet 372(9648):1502\u20131517. https:\/\/doi.org\/10.1016\/s0140-6736(08)61620-7","journal-title":"Lancet"},{"key":"1271_CR14","doi-asserted-by":"publisher","DOI":"10.1186\/s12883-017-0845-y","author":"D Delgado","year":"2017","unstructured":"Delgado D, Canham L, Cotterill N, Cottrell D, Drake MJ, Inglis K, Owen D, White P (2017) Protocol for a randomized, double blind, placebo controlled, crossover trial of Melatonin for treatment of Nocturia in adults with Multiple Sclerosis (MeNiMS). BMC Neurol. https:\/\/doi.org\/10.1186\/s12883-017-0845-y","journal-title":"BMC Neurol"},{"issue":"1","key":"1271_CR15","doi-asserted-by":"publisher","first-page":"107","DOI":"10.1186\/s12883-018-1114-4","volume":"18","author":"MJ Drake","year":"2018","unstructured":"Drake MJ, Canham L, Cotterill N, Delgado D, Homewood J, Inglis K, Johnson L, Kisanga MC, Owen D, White P, Cottrell D (2018) Results of a randomized, double blind, placebo controlled, crossover trial of melatonin for treatment of Nocturia in adults with multiple sclerosis (MeNiMS). BMC Neurol 18(1):107. https:\/\/doi.org\/10.1186\/s12883-018-1114-4","journal-title":"BMC Neurol"},{"key":"1271_CR16","doi-asserted-by":"publisher","DOI":"10.1155\/2016\/5857940","author":"S Emamgholipour","year":"2016","unstructured":"Emamgholipour S, Hossein-Nezhad A, Ansari M (2016a) Can melatonin act as an antioxidant in hydrogen peroxide-induced oxidative stress model in human peripheral blood mononuclear cells? Biochem Res Int. https:\/\/doi.org\/10.1155\/2016\/5857940","journal-title":"Biochem Res Int"},{"key":"1271_CR17","doi-asserted-by":"publisher","first-page":"34","DOI":"10.1016\/j.lfs.2015.12.014","volume":"145","author":"S Emamgholipour","year":"2016","unstructured":"Emamgholipour S, Hossein-Nezhad A, Sahraian MA, Askarisadr F, Ansari M (2016b) Evidence for possible role of melatonin in reducing oxidative stress in multiple sclerosis through its effect on SIRT1 and antioxidant enzymes. Life Sci 145:34\u201341. https:\/\/doi.org\/10.1016\/j.lfs.2015.12.014","journal-title":"Life Sci"},{"issue":"1","key":"1271_CR18","doi-asserted-by":"publisher","first-page":"205","DOI":"10.1007\/s00415-020-10381-w","volume":"269","author":"G Fatemeh","year":"2022","unstructured":"Fatemeh G, Sajjad M, Niloufar R, Neda S, Leila S, Khadijeh M (2022) Effect of melatonin supplementation on sleep quality: a systematic review and meta-analysis of randomized controlled trials. J Neurol 269(1):205\u2013216. https:\/\/doi.org\/10.1007\/s00415-020-10381-w","journal-title":"J Neurol"},{"key":"1271_CR19","unstructured":"Fuladi Targhi F, Faraji F, Maleki Rad AA, Ghassami K, Talaei A (2018) Study the effect of melatonin on fatigue in patients with multiple sclerosis [Original Atricle]. J Arak Univ Med Sci 21(6):67\u201375. http:\/\/jams.arakmu.ac.ir\/article-1-5562-en.html"},{"issue":"4","key":"1271_CR20","doi-asserted-by":"publisher","first-page":"427","DOI":"10.1111\/jpi.12134","volume":"56","author":"HF Galley","year":"2014","unstructured":"Galley HF, Lowes DA, Allen L, Cameron G, Aucott LS, Webster NR (2014) Melatonin as a potential therapy for sepsis: a phase I dose escalation study and an ex vivo whole blood model under conditions of sepsis. J Pineal Res 56(4):427\u2013438. https:\/\/doi.org\/10.1111\/jpi.12134","journal-title":"J Pineal Res"},{"issue":"2","key":"1271_CR21","doi-asserted-by":"publisher","first-page":"181","DOI":"10.1111\/fcp.12337","volume":"32","author":"M Ghareghani","year":"2018","unstructured":"Ghareghani M, Scavo L, Arnoult D, Zibara K, Farhadi N (2018) Melatonin therapy reduces the risk of osteoporosis and normalizes bone formation in multiple sclerosis. Fund Clin Pharmacol 32(2):181\u2013187. https:\/\/doi.org\/10.1111\/fcp.12337","journal-title":"Fund Clin Pharmacol"},{"key":"1271_CR22","doi-asserted-by":"publisher","first-page":"180","DOI":"10.1016\/j.bbi.2013.04.010","volume":"32","author":"D Golan","year":"2013","unstructured":"Golan D, Staun-Ram E, Glass-Marmor L, Lavi I, Rozenberg O, Dishon S, Barak M, Ish-Shalom S, Miller A (2013) The influence of vitamin D supplementation on melatonin status in patients with multiple sclerosis. Brain Behav Immun 32:180\u2013185. https:\/\/doi.org\/10.1016\/j.bbi.2013.04.010","journal-title":"Brain Behav Immun"},{"key":"1271_CR23","doi-asserted-by":"publisher","first-page":"103032","DOI":"10.1016\/j.msard.2021.103032","volume":"51","author":"CH Hawkes","year":"2021","unstructured":"Hawkes CH, Baker MD, Pohl D, Lechner-Scott J, Levy M, Giovannoni G (2021) Melatonin and multiple sclerosis. Mult Scler Relat Disord 51:103032. https:\/\/doi.org\/10.1016\/j.msard.2021.103032","journal-title":"Mult Scler Relat Disord"},{"issue":"1","key":"1271_CR24","doi-asserted-by":"publisher","first-page":"23","DOI":"10.34172\/jrcm.2022.023","volume":"10","author":"S Hosseini","year":"2022","unstructured":"Hosseini S, Yazdchi M, Sahraian MA, Majidi S, Taher S, Hassannezhad S, Mosaddeghi Heris R (2022) Fatigue in multiple sclerosis is a diagnostic challenge: a cross-sectional study. J Res Clin Med 10(1):23\u201323. https:\/\/doi.org\/10.34172\/jrcm.2022.023","journal-title":"J Res Clin Med"},{"issue":"4","key":"1271_CR25","doi-asserted-by":"publisher","first-page":"205521732110487","DOI":"10.1177\/20552173211048756","volume":"7","author":"W-Y Hsu","year":"2021","unstructured":"Hsu W-Y, Anderson A, Rowles W, Peters KE, Li V, Stone KL, Ashbrook LH, Gelfand AA, Bove RM (2021) Effects of melatonin on sleep disturbances in multiple sclerosis: a randomized, controlled pilot study. Mult Scler J Exp Transl Clin 7(4):20552173211048756. https:\/\/doi.org\/10.1177\/20552173211048756","journal-title":"Mult Scler J Exp Transl Clin"},{"key":"1271_CR26","doi-asserted-by":"publisher","DOI":"10.1080\/00207454.2022.2090353","author":"S Jallouli","year":"2022","unstructured":"Jallouli S, Ghroubi S, Dhia IB, Yahia A, Elleuch MH, Sakka S, Mhiri C, Hammouda O (2022) Effect of melatonin intake on postural balance, functional mobility and fall risk in persons with multiple sclerosis: a pilot study. Int J Neurosci. https:\/\/doi.org\/10.1080\/00207454.2022.2090353","journal-title":"Int J Neurosci"},{"key":"1271_CR27","unstructured":"Jamshidi Fard A, Rafipour H, Faraji F (2013) Effects of melatonin on visual functioning of patients with multiple sclerosis. J Arak Univ Med Sci 16(5):8\u201318. http:\/\/jams.arakmu.ac.ir\/article-1-2282-en.html"},{"key":"1271_CR28","doi-asserted-by":"crossref","unstructured":"Janalipour K (2019) Multiple sclerosis symptoms. In: Neurological disorders and imaging physics, Volume 2: engineering and clinical perspectives of multiple sclerosis. IOP Publishing","DOI":"10.1088\/978-0-7503-1762-7ch5"},{"issue":"11","key":"1271_CR29","doi-asserted-by":"publisher","first-page":"1805","DOI":"10.1084\/jem.20050011","volume":"201","author":"N Kawakami","year":"2005","unstructured":"Kawakami N, N\u00e4gerl UV, Odoardi F, Bonhoeffer T, Wekerle H, Fl\u00fcgel A (2005) Live imaging of effector cell trafficking and autoantigen recognition within the unfolding autoimmune encephalomyelitis lesion. J Exp Med 201(11):1805\u20131814. https:\/\/doi.org\/10.1084\/jem.20050011","journal-title":"J Exp Med"},{"key":"1271_CR30","doi-asserted-by":"publisher","DOI":"10.3390\/cells10040844","author":"H Koike","year":"2021","unstructured":"Koike H, Katsuno M (2021) Macrophages and autoantibodies in demyelinating diseases. Cells. https:\/\/doi.org\/10.3390\/cells10040844","journal-title":"Cells"},{"issue":"2","key":"1271_CR31","doi-asserted-by":"publisher","first-page":"173","DOI":"10.1111\/jpi.12203","volume":"58","author":"A L\u00f5pez-Gonz\u00e1lez","year":"2015","unstructured":"L\u00f5pez-Gonz\u00e1lez A, \u00c1lvarez-S\u00e1nchez N, Lardone PJ, Cruz-Chamorro I, Mart\u00ednez-L\u00f5pez A, Guerrero JM, Reiter RJ, Carrillo-Vico A (2015) Melatonin treatment improves primary progressive multiple sclerosis: a case report. J Pineal Res 58(2):173\u2013177. https:\/\/doi.org\/10.1111\/jpi.12203","journal-title":"J Pineal Res"},{"issue":"6","key":"1271_CR32","doi-asserted-by":"publisher","first-page":"1021","DOI":"10.1016\/j.exer.2006.10.018","volume":"84","author":"PO Lundmark","year":"2007","unstructured":"Lundmark PO, Pandi-Perumal SR, Srinivasan V, Cardinali DP, Rosenstein RE (2007) Melatonin in the eye: implications for glaucoma. Exp Eye Res 84(6):1021\u20131030. https:\/\/doi.org\/10.1016\/j.exer.2006.10.018","journal-title":"Exp Eye Res"},{"key":"1271_CR33","doi-asserted-by":"publisher","first-page":"4610522","DOI":"10.1155\/2022\/4610522","volume":"2022","author":"T Lv","year":"2022","unstructured":"Lv T, Yan J, Lou Y, Zhang Z, Ye M, Zhou J, Luo F, Bi C, Lin H, Zhang J, Guo H, Liu Z (2022) Evaluation of melatonin therapy in patients with myocardial ischemia-reperfusion injury: a systematic review and meta-analysis. Oxid Med Cell Longev 2022:4610522. https:\/\/doi.org\/10.1155\/2022\/4610522","journal-title":"Oxid Med Cell Longev"},{"issue":"2","key":"1271_CR34","doi-asserted-by":"publisher","first-page":"e12782","DOI":"10.1111\/jpi.12782","volume":"72","author":"Z Menczel Schrire","year":"2022","unstructured":"Menczel Schrire Z, Phillips CL, Chapman JL, Duffy SL, Wong G, D\u2019Rozario AL, Comas M, Raisin I, Saini B, Gordon CJ, McKinnon AC, Naismith SL, Marshall NS, Grunstein RR, Hoyos CM (2022) Safety of higher doses of melatonin in adults: a systematic review and meta-analysis. J Pineal Res 72(2):e12782. https:\/\/doi.org\/10.1111\/jpi.12782","journal-title":"J Pineal Res"},{"key":"1271_CR35","doi-asserted-by":"publisher","first-page":"58","DOI":"10.1186\/1471-2377-14-58","volume":"14","author":"S Meyer-Moock","year":"2014","unstructured":"Meyer-Moock S, Feng YS, Maeurer M, Dippel FW, Kohlmann T (2014) Systematic literature review and validity evaluation of the Expanded Disability Status Scale (EDSS) and the Multiple Sclerosis Functional Composite (MSFC) in patients with multiple sclerosis. BMC Neurol 14:58. https:\/\/doi.org\/10.1186\/1471-2377-14-58","journal-title":"BMC Neurol"},{"issue":"8","key":"1271_CR36","doi-asserted-by":"publisher","first-page":"406","DOI":"10.1016\/j.jtherbio.2010.08.006","volume":"35","author":"E Miller","year":"2010","unstructured":"Miller E, Mrowicka M, Malinowska K, Mrowicki J, Saluk-Juszczak J, Kedziora J (2010) The effects of whole-body cryotherapy on oxidative stress in multiple sclerosis patients. J Therm Biol 35(8):406\u2013410. https:\/\/doi.org\/10.1016\/j.jtherbio.2010.08.006","journal-title":"J Therm Biol"},{"issue":"1\u20132","key":"1271_CR37","doi-asserted-by":"publisher","first-page":"97","DOI":"10.1016\/j.jneuroim.2013.02.012","volume":"257","author":"E Miller","year":"2013","unstructured":"Miller E, Walczak A, Majsterek I, Kedziora J (2013) Melatonin reduces oxidative stress in the erythrocytes of multiple sclerosis patients with secondary progressive clinical course. J Neuroimmunol 257(1\u20132):97\u2013101. https:\/\/doi.org\/10.1016\/j.jneuroim.2013.02.012","journal-title":"J Neuroimmunol"},{"key":"1271_CR38","unstructured":"Miller E, Mrowicka M, Malinowska K, Kedziora J, Majsterek I (2011) The effects of whole-body cryotherapy and melatonin supplementation on total antioxidative status and some antioxidative enzymes in multiple sclerosis patients. Wplyw krioterapii ogolnoustrojowej i suplementacji melatonina na calkowity potencjal antyoksydacyjny w osoczu oraz aktywnosc wybranych enzymow antyoksydacyjnych w erytrocytach chorych na stwardnlenie rozsiane 31(183):150\u2013153. http:\/\/ovidsp.ovid.com\/ovidweb.cgi?T=JS&PAGE=reference&D=med8&NEWS=N&AN=21991843"},{"key":"1271_CR39","doi-asserted-by":"publisher","first-page":"105210","DOI":"10.1016\/j.phrs.2020.105210","volume":"161","author":"M Morvaridzadeh","year":"2020","unstructured":"Morvaridzadeh M, Sadeghi E, Agah S, Nachvak SM, Fazelian S, Moradi F, Persad E, Heshmati J (2020) Effect of melatonin supplementation on oxidative stress parameters: a systematic review and meta-analysis. Pharmacol Res 161:105210. https:\/\/doi.org\/10.1016\/j.phrs.2020.105210","journal-title":"Pharmacol Res"},{"key":"1271_CR40","unstructured":"Mrowicka M, Garncarek P, Miller E, Kedziora J, Smigielski J, Malinowska K, Mrowicki J (2010) Effect of melatonin on activity of superoxide dismutase (CuZn-SOD) in erythrocytes of patients during short- and long-term hypokinesis. Wplyw melatoniny na aktywnosc dysmutazy ponadtlenkowej (CuZn-SOD) w krwinkach czerwonych chorych w okresie hipokinezji krotko- i dlugoterminowej 63(1), 3\u20139. http:\/\/ovidsp.ovid.com\/ovidweb.cgi?T=JS&PAGE=reference&D=med8&NEWS=N&AN=20701024"},{"key":"1271_CR41","doi-asserted-by":"publisher","DOI":"10.1007\/s10787-022-01011-0","author":"A Munoz-Jurado","year":"2022","unstructured":"Munoz-Jurado A, Escribano BM, Caballero-Villarraso J, Galvan A, Aguera E, Santamaria A, Tunez I (2022) Melatonin and multiple sclerosis: antioxidant, anti-inflammatory and immunomodulator mechanism of action. Inflammopharmacology. https:\/\/doi.org\/10.1007\/s10787-022-01011-0","journal-title":"Inflammopharmacology"},{"key":"1271_CR42","doi-asserted-by":"publisher","first-page":"103432","DOI":"10.1016\/j.msard.2021.103432","volume":"57","author":"A Naseri","year":"2022","unstructured":"Naseri A, Forghani N, Sadigh-Eteghad S, Shanehbandi D, Asadi M, Nasiri E, Talebi M (2022) Circulatory antioxidant and oxidative stress markers are in correlation with demographics but not cognitive functions in multiple sclerosis patients. Mult Scler Relat Disord 57:103432. https:\/\/doi.org\/10.1016\/j.msard.2021.103432","journal-title":"Mult Scler Relat Disord"},{"issue":"1","key":"1271_CR43","doi-asserted-by":"publisher","first-page":"468","DOI":"10.1186\/s12883-021-02396-1","volume":"21","author":"A Oliva Ramirez","year":"2021","unstructured":"Oliva Ramirez A, Keenan A, Kalau O, Worthington E, Cohen L, Singh S (2021) Prevalence and burden of multiple sclerosis-related fatigue: a systematic literature review. BMC Neurol 21(1):468. https:\/\/doi.org\/10.1186\/s12883-021-02396-1","journal-title":"BMC Neurol"},{"key":"1271_CR44","doi-asserted-by":"publisher","first-page":"n71","DOI":"10.1136\/bmj.n71","volume":"372","author":"MJ Page","year":"2021","unstructured":"Page MJ, McKenzie JE, Bossuyt PM, Boutron I, Hoffmann TC, Mulrow CD, Shamseer L, Tetzlaff JM, Akl EA, Brennan SE, Chou R, Glanville J, Grimshaw JM, Hr\u00f3bjartsson A, Lalu MM, Li T, Loder EW, Mayo-Wilson E, McDonald S, Moher D (2021) The PRISMA 2020 statement: an updated guideline for reporting systematic reviews. BMJ 372:n71. https:\/\/doi.org\/10.1136\/bmj.n71","journal-title":"BMJ"},{"key":"1271_CR45","unstructured":"Roostaei T, Sahraian MA, Hajeaghaee S, Gholipour T, Togha M, Siroos B, Mansouri S, Mohammadshirazi Z, Aghazadeh Alasti M, Harirchian MH (2015) Impact of melatonin on motor, cognitive and neuroimaging indices in patients with multiple sclerosis. Iran J Allergy Asthma Immunol 14(6):589\u2013595. http:\/\/ovidsp.ovid.com\/ovidweb.cgi?T=JS&PAGE=reference&D=med12&NEWS=N&AN=26725556https:\/\/ijaai.tums.ac.ir\/index.php\/ijaai\/article\/download\/611\/576"},{"issue":"5","key":"1271_CR46","doi-asserted-by":"publisher","first-page":"1346","DOI":"10.1080\/13813455.2020.1770799","volume":"128","author":"S Samanta","year":"2022","unstructured":"Samanta S (2022) Physiological and pharmacological perspectives of melatonin. Arch Physiol Biochem 128(5):1346\u20131367. https:\/\/doi.org\/10.1080\/13813455.2020.1770799","journal-title":"Arch Physiol Biochem"},{"issue":"6","key":"1271_CR47","doi-asserted-by":"publisher","first-page":"391","DOI":"10.1016\/j.arcmed.2018.12.004","volume":"49","author":"AL S\u00e1nchez-L\u00f3pez","year":"2018","unstructured":"S\u00e1nchez-L\u00f3pez AL, Ortiz GG, Pacheco-Moises FP, Mireles-Ram\u00edrez MA, Bitzer-Quintero OK, Delgado-Lara DLC, Ram\u00edrez-Jirano LJ, Vel\u00e1zquez-Brizuela IE (2018) Efficacy of melatonin on serum pro-inflammatory cytokines and oxidative stress markers in relapsing remitting multiple sclerosis. Arch Med Res 49(6):391\u2013398. https:\/\/doi.org\/10.1016\/j.arcmed.2018.12.004","journal-title":"Arch Med Res"},{"key":"1271_CR48","unstructured":"Savage RA, Zafar N, Yohannan S, Miller JMM (2023) Melatonin. In: StatPearls. StatPearls Publishing Copyright \u00a9 2023, StatPearls Publishing LLC"},{"issue":"6","key":"1271_CR49","doi-asserted-by":"publisher","first-page":"2291","DOI":"10.1007\/s10072-020-04807-6","volume":"42","author":"M Talebi","year":"2021","unstructured":"Talebi M, Majdi A, Nasiri E, Naseri A, Sadigh-Eteghad S (2021) The correlation between circulating inflammatory, oxidative stress, and neurotrophic factors level with the cognitive outcomes in multiple sclerosis patients. Neurol Sci 42(6):2291\u20132300. https:\/\/doi.org\/10.1007\/s10072-020-04807-6","journal-title":"Neurol Sci"},{"key":"1271_CR50","doi-asserted-by":"crossref","unstructured":"Tryfonos C, Mantzorou M, Fotiou D, Vrizas M, Vadikolias K, Pavlidou E, Giaginis C (2019) Dietary supplements on controlling multiple sclerosis symptoms and relapses: current clinical evidence and future perspectives. Medicines 6(3):95. https:\/\/www.mdpi.com\/2305-6320\/6\/3\/95","DOI":"10.3390\/medicines6030095"},{"key":"1271_CR51","doi-asserted-by":"crossref","unstructured":"Tufanaru C, Munn Z, Aromataris E, Campbell J, Hopp LAE, Munn Z (2020) Chapter 3: systematic reviews of effectiveness. JBI Manual for Evidence Synthesis. Adelaide: JBI [cited 2020 Feb 10]. In.","DOI":"10.46658\/JBIRM-17-03"},{"key":"1271_CR52","doi-asserted-by":"publisher","unstructured":"Walton C, King R, Rechtman L, Kaye W, Leray E, Marrie RA, Robertson N, La Rocca N, Uitdehaag B, van der Mei I, Wallin M, Helme A, Angood NC, Rijke N, Baneke P (2020) Rising prevalence of multiple sclerosis worldwide: insights from the Atlas of MS, third edition. Mult Scler 26(14):1816\u20131821. https:\/\/doi.org\/10.1177\/1352458520970841","DOI":"10.1177\/1352458520970841"},{"issue":"Suppl","key":"1271_CR53","doi-asserted-by":"publisher","first-page":"S47","DOI":"10.1002\/ana.410360714","volume":"36","author":"H Wekerle","year":"1994","unstructured":"Wekerle H, Kojima K, Lannes-Vieira J, Lassmann H, Linington C (1994) Animal models. Ann Neurol 36(Suppl):S47-53. https:\/\/doi.org\/10.1002\/ana.410360714","journal-title":"Ann Neurol"},{"issue":"1\u20132","key":"1271_CR54","doi-asserted-by":"publisher","first-page":"16","DOI":"10.1016\/j.jneuroim.2007.09.007","volume":"191","author":"DO Willenborg","year":"2007","unstructured":"Willenborg DO, Staykova M, Fordham S, O\u2019Brien N, Linares D (2007) The contribution of nitric oxide and interferon gamma to the regulation of the neuro-inflammation in experimental autoimmune encephalomyelitis. J Neuroimmunol 191(1\u20132):16\u201325. https:\/\/doi.org\/10.1016\/j.jneuroim.2007.09.007","journal-title":"J Neuroimmunol"},{"issue":"2","key":"1271_CR55","doi-asserted-by":"publisher","first-page":"66","DOI":"10.18502\/cjn.v21i2.10489","volume":"21","author":"M Yazdchi","year":"2022","unstructured":"Yazdchi M, Khanalizadeh R, Nasiri E, Naseri A, Talebi M, Talebi M (2022) Sleep status in multiple sclerosis: Role of vitamin D and body mass index. Curr J Neurol 21(2):66\u201373. https:\/\/doi.org\/10.18502\/cjn.v21i2.10489","journal-title":"Curr J Neurol"},{"issue":"7","key":"1271_CR56","doi-asserted-by":"publisher","first-page":"607","DOI":"10.1007\/s40261-019-00793-6","volume":"39","author":"M Yeganeh Salehpour","year":"2019","unstructured":"Yeganeh Salehpour M, Mollica A, Momtaz S, Sanadgol N, Farzaei MH (2019) Melatonin and multiple sclerosis: from plausible neuropharmacological mechanisms of action to experimental and clinical evidence. Clin Drug Investig 39(7):607\u2013624. https:\/\/doi.org\/10.1007\/s40261-019-00793-6","journal-title":"Clin Drug Investig"},{"issue":"6","key":"1271_CR57","doi-asserted-by":"publisher","first-page":"649","DOI":"10.18502\/ijaai.v18i6.2177","volume":"18","author":"M Yosefifard","year":"2019","unstructured":"Yosefifard M, Vaezi G, Malekirad AA, Faraji F, Hojati V (2019a) A randomized control trial study to determine the effect of melatonin on serum levels of IL-1beta and TNF-alpha in patients with multiple sclerosis. Iran J Allergy Asthma Immunol 18(6):649\u2013654. https:\/\/doi.org\/10.18502\/ijaai.v18i6.2177","journal-title":"Iran J Allergy Asthma Immunol"},{"issue":"6","key":"1271_CR58","doi-asserted-by":"publisher","first-page":"649","DOI":"10.18502\/ijaai.v18i6.2177","volume":"18","author":"M Yosefifard","year":"2019","unstructured":"Yosefifard M, Vaezi G, Malekirad AA, Faraji F, Hojati V (2019b) A randomized control trial study to determine the effect of melatonin on serum levels of IL-1\u03b2 and TNF-\u03b1 in patients with multiple sclerosis. Iran J Allergy Asthma Immunol 18(6):649\u2013654. https:\/\/doi.org\/10.18502\/ijaai.v18i6.2177","journal-title":"Iran J Allergy Asthma Immunol"},{"issue":"1","key":"1271_CR59","doi-asserted-by":"publisher","first-page":"19","DOI":"10.32598\/ijt.14.1.19","volume":"14","author":"M Yosefi-Fard","year":"2020","unstructured":"Yosefi-Fard M, Vaezi G, Maleki-Rad AA, Faraji F, Hojati V (2020) Effect of melatonin on serum levels of inf-1\u00df and vitamin b12 in patients with multiple sclerosis: a randomized controlled trial. Iran J Toxicol 14(1):19\u201324. https:\/\/doi.org\/10.32598\/ijt.14.1.19","journal-title":"Iran J Toxicol"},{"key":"1271_CR60","doi-asserted-by":"publisher","first-page":"109","DOI":"10.1016\/j.clnesp.2022.01.038","volume":"48","author":"M Zarezadeh","year":"2022","unstructured":"Zarezadeh M, Barzegari M, Aghapour B, Adeli S, Khademi F, Musazadeh V, Jamilian P, Jamilian P, Fakhr L, Chehregosha F, Ghoreishi Z, Ostadrahimi A (2022) Melatonin effectiveness in amelioration of oxidative stress and strengthening of antioxidant defense system: Findings from a systematic review and dose-response meta-analysis of controlled clinical trials. Clin Nutr ESPEN 48:109\u2013120. https:\/\/doi.org\/10.1016\/j.clnesp.2022.01.038","journal-title":"Clin Nutr ESPEN"},{"issue":"1","key":"1271_CR61","doi-asserted-by":"publisher","first-page":"57","DOI":"10.1007\/s10072-015-2357-0","volume":"37","author":"W Zhang","year":"2016","unstructured":"Zhang W, Chen XY, Su SW, Jia QZ, Ding T, Zhu ZN, Zhang T (2016) Exogenous melatonin for sleep disorders in neurodegenerative diseases: a meta-analysis of randomized clinical trials. Neurol Sci 37(1):57\u201365. https:\/\/doi.org\/10.1007\/s10072-015-2357-0","journal-title":"Neurol Sci"},{"key":"1271_CR62","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.cytogfr.2019.07.002","volume":"48","author":"CN Zhao","year":"2019","unstructured":"Zhao CN, Wang P, Mao YM, Dan YL, Wu Q, Li XM, Wang DG, Davis C, Hu W, Pan HF (2019) Potential role of melatonin in autoimmune diseases. Cytokine Growth Factor Rev 48:1\u201310. https:\/\/doi.org\/10.1016\/j.cytogfr.2019.07.002","journal-title":"Cytokine Growth Factor Rev"}],"container-title":["Inflammopharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10787-023-01271-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s10787-023-01271-4\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10787-023-01271-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,9,25]],"date-time":"2023-09-25T01:10:47Z","timestamp":1695604247000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s10787-023-01271-4"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,7,10]]},"references-count":62,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2023,10]]}},"alternative-id":["1271"],"URL":"https:\/\/doi.org\/10.1007\/s10787-023-01271-4","relation":{},"ISSN":["0925-4692","1568-5608"],"issn-type":[{"value":"0925-4692","type":"print"},{"value":"1568-5608","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,7,10]]},"assertion":[{"value":"1 June 2023","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"10 June 2023","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"10 July 2023","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors have not disclosed any competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"The ethics committee of Tabriz University of Medical Science reviewed and approved the study protocol (Ethics code: IR.TBZMED.VCR.REC.1401.293).","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval"}},{"value":"Not applicable.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}}]}}